CD8+ T cells responding to CRC-associated antigens MUC1, HER2/neu, CEA, TP53, and heparanase were observed [40,90], without apparent differences as compared to primary tumors [40]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.